Print Page

给 医 护 专 业 人 员 的 信
 
PRAC recommends new measures to avoid topiramate exposure in pregnancy (Letter to Healthcare Professionals) (English only)
 
 
 
附件:
  1. PRAC recommends new measures to avoid topiramate exposure in pregnancy (English only)  
Related Information:
Singapore: TOPAMAX® (topiramate): Safety measures to prevent exposure during pre... 上载于 2024-11-08
The United Kingdom: Topiramate (Topamax): introduction of new safety measures, i... 上载于 2024-06-21
European Union: PRAC recommends new measures to avoid topiramate exposure in pre... 上载于 2023-09-04
Singapore: TOPAMAX® (topiramate) TABLETS 25mg, 50mg and 100mg: Risk of neurodeve... 上载于 2023-03-07
European Union: PRAC starts review of topiramate use in pregnancy and women of c... 上载于 2022-09-03
The United Kingdom: Topiramate (Topamax): Start of safety review triggered by a ... 上载于 2022-07-22
European Union: PRAC starts review on risk of neurodevelopmental disorders with ... 上载于 2022-07-09
 
back